Alpha Pro Tech (APT) Competitors $4.77 +0.08 (+1.71%) Closing price 04:00 PM EasternExtended Trading$5.06 +0.29 (+6.10%) As of 05:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock APT vs. BWAY, DRTS, SKIN, PROF, BSGM, INGN, ELMD, KRMD, CVRX, and AVRShould you be buying Alpha Pro Tech stock or one of its competitors? The main competitors of Alpha Pro Tech include Brainsway (BWAY), Alpha Tau Medical (DRTS), Beauty Health (SKIN), Profound Medical (PROF), Biosig Technologies (BSGM), Inogen (INGN), Electromed (ELMD), KORU Medical Systems (KRMD), CVRx (CVRX), and Anteris Technologies Global (AVR). These companies are all part of the "medical equipment" industry. Alpha Pro Tech vs. Its Competitors Brainsway Alpha Tau Medical Beauty Health Profound Medical Biosig Technologies Inogen Electromed KORU Medical Systems CVRx Anteris Technologies Global Brainsway (NASDAQ:BWAY) and Alpha Pro Tech (NYSE:APT) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment. Is BWAY or APT more profitable? Brainsway has a net margin of 9.01% compared to Alpha Pro Tech's net margin of 6.99%. Brainsway's return on equity of 7.35% beat Alpha Pro Tech's return on equity.Company Net Margins Return on Equity Return on Assets Brainsway9.01% 7.35% 4.72% Alpha Pro Tech 6.99%6.70%5.76% Do analysts prefer BWAY or APT? Brainsway presently has a consensus price target of $14.25, suggesting a potential upside of 9.78%. Given Brainsway's stronger consensus rating and higher probable upside, analysts clearly believe Brainsway is more favorable than Alpha Pro Tech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Brainsway 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Alpha Pro Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings and valuation, BWAY or APT? Alpha Pro Tech has higher revenue and earnings than Brainsway. Alpha Pro Tech is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrainsway$41.02M5.98$2.92M$0.2064.90Alpha Pro Tech$58.18M0.89$4.19M$0.3712.89 Which has more risk & volatility, BWAY or APT? Brainsway has a beta of 1.4, indicating that its stock price is 40% more volatile than the S&P 500. Comparatively, Alpha Pro Tech has a beta of 0.34, indicating that its stock price is 66% less volatile than the S&P 500. Does the media refer more to BWAY or APT? In the previous week, Alpha Pro Tech had 1 more articles in the media than Brainsway. MarketBeat recorded 4 mentions for Alpha Pro Tech and 3 mentions for Brainsway. Brainsway's average media sentiment score of 0.85 beat Alpha Pro Tech's score of 0.15 indicating that Brainsway is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Brainsway 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Pro Tech 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of BWAY or APT? 30.1% of Brainsway shares are held by institutional investors. Comparatively, 22.7% of Alpha Pro Tech shares are held by institutional investors. 19.0% of Brainsway shares are held by company insiders. Comparatively, 15.0% of Alpha Pro Tech shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryBrainsway beats Alpha Pro Tech on 11 of the 16 factors compared between the two stocks. Get Alpha Pro Tech News Delivered to You Automatically Sign up to receive the latest news and ratings for APT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APT vs. The Competition Export to ExcelMetricAlpha Pro TechSurgical appliances & supplies IndustryIndustrials SectorNYSE ExchangeMarket Cap$51.82M$27.72M$7.52B$20.44BDividend YieldN/AN/A4.56%3.76%P/E Ratio12.8912.8924.5427.62Price / Sales0.892.31114.5436.30Price / Cash12.8012.8026.5317.85Price / Book0.902.244.334.55Net Income$4.19M-$5.31M$790.28M$984.47M7 Day Performance-1.04%-6.73%2.25%1.83%1 Month Performance1.06%-9.91%4.40%4.99%1 Year Performance-19.97%-7.73%30.82%14.00% Alpha Pro Tech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APTAlpha Pro Tech1.612 of 5 stars$4.77+1.7%N/A-14.7%$51.82M$58.18M12.89120BWAYBrainsway1.451 of 5 stars$11.49+5.3%$14.25+24.0%+116.6%$206.14M$41.02M57.45120DRTSAlpha Tau Medical2.5368 of 5 stars$2.98+2.8%$8.00+168.5%+23.3%$204.10MN/A-6.4880SKINBeauty Health0.3938 of 5 stars$1.93+19.9%$1.42-26.6%-0.5%$202.85M$334.30M-4.711,030High Trading VolumePROFProfound Medical2.4636 of 5 stars$6.01-5.4%$11.50+91.3%-29.7%$190.84M$11.86M-4.93150BSGMBiosig Technologies1.1812 of 5 stars$7.44+11.0%$10.00+34.4%+1,939.4%$182.87M$40K0.0050High Trading VolumeINGNInogen4.2995 of 5 stars$6.67+0.5%$11.00+64.9%-13.5%$178.53M$335.70M-5.801,030ELMDElectromed1.2221 of 5 stars$21.25+3.5%$38.00+78.8%+46.3%$178.20M$61.44M28.33160KRMDKORU Medical Systems2.2311 of 5 stars$3.43+1.5%$4.50+31.2%+35.1%$155.96M$33.65M-31.1880News CoverageHigh Trading VolumeCVRXCVRx2.7271 of 5 stars$5.72-2.4%$14.50+153.5%-51.0%$152.79M$51.29M-2.62160News CoveragePositive NewsAVRAnteris Technologies GlobalN/A$3.80-6.6%$16.50+334.2%N/A$146.77M$2.70M0.00138 Related Companies and Tools Related Companies Brainsway Competitors Alpha Tau Medical Competitors Beauty Health Competitors Profound Medical Competitors Biosig Technologies Competitors Inogen Competitors Electromed Competitors KORU Medical Systems Competitors CVRx Competitors Anteris Technologies Global Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:APT) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Pro Tech, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Pro Tech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.